Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trialRick Admiraal, Jaap Jan Boelens, Stefan Nierkens et al.|The Lancet Haematology|2022Cited by 71
Prospective Open-Label Phase II Trial of Individualized Anti-Thymocyte Globulin for Improved T-Cell Reconstitution after Pediatric Allogeneic Hematopoietic Cell Transplantation: The Parachute-StudyRick Admiraal, Jaap Jan Boelens, Stefan Nierkens et al.|Transplantation and Cellular Therapy|2020Cited by 10
Front & Back MatterSo‐Yeon Shim, Рамазан Оздемир, Hye-Jin Jeong et al.|Neonatology|2012Cited by 0
Acknowledgement to the ReviewersSo‐Yeon Shim, Рамазан Оздемир, Lorayne Barton et al.|Neonatology|2012Cited by 0